Skip to main content
. 2015 May 6;10(5):e0123665. doi: 10.1371/journal.pone.0123665

Table 2. Reproductive characteristics of the study population.

Variables Osteoporosis (n = 673) Non-osteoporosis (n = 1857) P value
Age at menarche, years 16.20 ± 2.01 15.70 ± 1.91 <0.0001
Age at menopause, years 50.70 ± 3.09 50.82 ± 2.87 0.128 1
Gravidity, n 5.69 ± 8.78 5.58 ± 9.47 0.792
Time from menarche to first delivery, years 7.77 ± 3.85 8.49 ± 3.99 <0.0001
Time since menopause, years 12.07 ± 6.14 7.70 ± 5.88 <0.0001
Age at first delivery, years 23.96 ± 3.19 24.15 ± 3.33 0.207
First delivery age groups, n (%) ≤23 years 310 (46.5%) 821 (44.6%) 0.053
24–29 years 331 (49.7%) 903 (49.1%)
≥30 years 25 (3.8%) 115 (6.3%)
Time from menarche to first delivery, n (%) ≤5 years 199 (30.6%) 437 (24.2%) 0.021
6–10 years 300 (46.1%) 860 (47.6%)
11–15 years 134 (20.6%) 430 (23.8%)
16–20 years 16 (2.5%) 70 (3.9%)
21–25 years 2 (0.3%) 8 (0.4%)
26–30 years 0 (0%) 1 (0%)
History of breast feeding, n (%) Yes 289 (95.1%) 838 (90.4%) 0.012
No 15 (4.9%) 89 (9.6%)
Total duration of breast feeding groups, n (%) ≤24 months 83 (28.8%) 368 (44.0%) <0.0001
25–48 months 94 (32.6%) 265(31.7%)
49–72 months 55 (19.1%) 112 (13.4%)
≥73 months 56 (19.4%) 91 (10.9%)
History of OC use, n (%) Yes 147 (21.9%) 494 (26.7%) 0.017
No 523 (78.1%) 1358 (73.3%)
History of HT use, n (%) Yes 85 (12.7%) 401 (21.7%) <0.0001
No 585 (87.3%) 1447 (78.3%)

1Mann—Whitney U test was performed for continuous variables that did not show normal distribution.

OC, oral contraceptive; HT, hormone therapy.

Data are presented as the mean ± standard deviation.

P values were obtained using the 2-sample t-test for continuous variables and the chi-square test for categorical variables.